
U.S. Physical (USPH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
183.8M
Gross Profit
31.1M
16.90%
Operating Income
14.8M
8.06%
Net Income
13.5M
7.33%
EPS (Diluted)
$0.80
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
420.7M
Shareholders Equity
759.0M
Debt to Equity
0.55
Cash Flow Metrics
Operating Cash Flow
8.0M
Free Cash Flow
-7.3M
Revenue & Profitability Trend
U.S. Physical Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 671.3M | 604.8M | 553.1M | 495.0M | 423.0M |
Cost of Goods Sold | 547.4M | 483.3M | 441.1M | 377.8M | 328.5M |
Gross Profit | 123.9M | 121.5M | 112.0M | 117.2M | 94.4M |
Gross Margin % | 18.5% | 20.1% | 20.3% | 23.7% | 22.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 46.1M | 46.5M | 42.0M |
Other Operating Expenses | 58.3M | 51.5M | 46.1M | 41.9M | 28.5M |
Total Operating Expenses | 58.3M | 51.5M | 92.2M | 88.5M | 70.6M |
Operating Income | 65.6M | 70.0M | 65.9M | 75.2M | 65.9M |
Operating Margin % | 9.8% | 11.6% | 11.9% | 15.2% | 15.6% |
Non-Operating Items | |||||
Interest Income | 3.9M | 3.8M | 0 | 0 | 142.0K |
Interest Expense | 8.0M | 9.3M | 5.8M | 942.0K | 1.6M |
Other Non-Operating Income | -1.3M | -15.1M | -4.6M | -1.1M | 1.1M |
Pre-tax Income | 60.2M | 49.4M | 55.6M | 73.2M | 65.5M |
Income Tax | 14.6M | 12.2M | 12.2M | 15.3M | 13.0M |
Effective Tax Rate % | 24.3% | 24.6% | 21.9% | 20.9% | 19.9% |
Net Income | 45.6M | 37.2M | 43.4M | 57.9M | 52.5M |
Net Margin % | 6.8% | 6.2% | 7.8% | 11.7% | 12.4% |
Key Metrics | |||||
EBITDA | 89.6M | 90.8M | 82.7M | 88.4M | 76.6M |
EPS (Basic) | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 |
EPS (Diluted) | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 |
Basic Shares Outstanding | 15064000 | 14188000 | 12985000 | 12898000 | 12835000 |
Diluted Shares Outstanding | 15064000 | 14188000 | 12985000 | 12898000 | 12835000 |
Income Statement Trend
U.S. Physical Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 41.4M | 152.8M | 31.6M | 28.6M | 32.9M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 59.0M | 69.7M | 68.6M | 46.3M | 41.9M |
Inventory | - | - | - | - | - |
Other Current Assets | 10.6M | 10.8M | 11.1M | 4.2M | 3.8M |
Total Current Assets | 137.6M | 233.4M | 111.3M | 95.2M | 87.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 133.9M | 103.4M | 103.0M | 96.4M | 81.6M |
Goodwill | 1.5B | 1.1B | 1.1B | 955.7M | 747.6M |
Intangible Assets | 179.3M | 109.7M | 108.8M | 86.4M | 56.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 5.2M | 2.8M | 4.1M | 1.6M | 1.5M |
Total Non-Current Assets | 1.0B | 763.9M | 746.9M | 654.3M | 506.7M |
Total Assets | 1.2B | 997.2M | 858.2M | 749.4M | 594.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 5.9M | 3.9M | 6.5M | 6.5M | 1.3M |
Short-term Debt | 50.8M | 42.9M | 41.6M | 31.3M | 32.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 116.3M | 102.2M | 85.5M | 83.5M | 93.5M |
Non-Current Liabilities | |||||
Long-term Debt | 244.4M | 215.6M | 253.8M | 191.8M | 78.6M |
Deferred Tax Liabilities | 29.5M | 24.8M | 21.3M | 14.4M | 7.8M |
Other Non-Current Liabilities | 18.3M | 2.4M | 13.0M | 7.3M | 4.5M |
Total Non-Current Liabilities | 292.1M | 242.8M | 288.1M | 213.5M | 90.9M |
Total Liabilities | 408.4M | 345.0M | 373.6M | 297.0M | 184.4M |
Equity | |||||
Common Stock | 172.0K | 172.0K | 152.0K | 151.0K | 151.0K |
Retained Earnings | 227.3M | 223.8M | 232.9M | 224.4M | 212.0M |
Treasury Stock | 31.6M | 31.6M | 31.6M | 31.6M | 31.6M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 759.0M | 652.2M | 484.6M | 452.4M | 410.0M |
Key Metrics | |||||
Total Debt | 295.2M | 258.6M | 295.3M | 223.1M | 111.0M |
Working Capital | 21.3M | 131.2M | 25.8M | 11.7M | -5.9M |
Balance Sheet Composition
U.S. Physical Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 45.6M | 37.2M | 43.4M | 57.9M | 52.5M |
Depreciation & Amortization | 18.7M | 15.7M | 14.7M | 11.6M | 10.5M |
Stock-Based Compensation | 7.8M | 7.2M | 7.3M | 7.9M | 7.9M |
Working Capital Changes | -14.1M | -4.9M | -14.0M | -16.4M | 15.7M |
Operating Cash Flow | 64.1M | 59.1M | 53.4M | 66.6M | 86.7M |
Investing Activities | |||||
Capital Expenditures | -9.2M | -9.3M | -8.2M | -8.2M | -7.6M |
Acquisitions | -142.0M | -36.9M | -74.3M | -116.1M | -43.6M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -150.5M | -45.8M | -82.5M | -124.3M | -51.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -26.5M | -24.1M | -21.3M | -18.8M | -4.1M |
Debt Issuance | 19.0M | 24.0M | 251.0M | 316.0M | 214.0M |
Debt Repayment | -14.7M | -63.2M | -186.8M | -222.9M | -245.0M |
Financing Cash Flow | -37.0M | 84.3M | 25.8M | 141.4M | -69.4M |
Free Cash Flow | 65.8M | 72.7M | 50.3M | 68.2M | 92.4M |
Net Change in Cash | -123.4M | 97.5M | -3.3M | 83.6M | -34.0M |
Cash Flow Trend
U.S. Physical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.46
Forward P/E
29.58
Price to Book
2.60
Price to Sales
1.81
PEG Ratio
1.60
Profitability Ratios
Profit Margin
5.28%
Operating Margin
12.40%
Return on Equity
7.45%
Return on Assets
4.24%
Financial Health
Current Ratio
1.18
Debt to Equity
39.89
Beta
1.45
Per Share Data
EPS (TTM)
$2.29
Book Value per Share
$32.94
Revenue per Share
$47.75
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
usph | 1.3B | 37.46 | 2.60 | 7.45% | 5.28% | 39.89 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.9B | 13.80 | 0.62 | 4.83% | 4.31% | 74.74 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.